Navis Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-750
| Closed | -$788K | – | 108 |
|
|
2024
Q3 | $788K | Hold |
750
| – | – | 0.85% | 25 |
|
|
2024
Q2 | $788K | Buy |
750
+150
| +25% | +$158K | 0.9% | 22 |
|
|
2024
Q1 | $577K | Sell |
600
-520
| -46% | -$500K | 0.69% | 35 |
|
|
2023
Q4 | $984K | Sell |
1,120
-150
| -12% | -$132K | 1.28% | 15 |
|
|
2023
Q3 | $1.05M | Buy |
1,270
+5
| +0.4% | +$4.12K | 1.51% | 14 |
|
|
2023
Q2 | $909K | Hold |
1,265
| – | – | 0.83% | 18 |
|
|
2023
Q1 | $1.04M | Buy |
+1,265
| New | +$1.04M | 1.14% | 15 |
|